Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Biogen's disease-modifying psoriasis therapy maintains efficacy upon retreatment

March 7, 2001

Positive phase III results announced for Metvix PDTas treatment of actinic keratosis

March 7, 2001

Phase IIa trial results presented at AAD meeting for ABX-IL-8 in psoriasis

March 6, 2001

AAD news: antipsoriatic activity of low-dose Ontak confirmed in pilot trial

March 6, 2001

Sustained clinical activity reported in IDEC-114 phase I/II trial for psoriasis

March 6, 2001

FDA requests additional information for Dermagraft PMA

Feb. 27, 2001

Novel antipruritic agents in development at Pfizer

Feb. 23, 2001

Access reports positive phase III data for OraDisc canker sore treatment

Feb. 21, 2001

Botulinum toxin type A preparation proves safe and effective in axillary hyperhidrosis

Feb. 21, 2001

Cellegy accelerates filing for Anogesic in Canada

Feb. 21, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...